April 21, 2017
The Pharmaceutical Research and Manufacturers of America (PhRMA) on April 20 submitted a paper summarizing its views on the envisaged drug pricing overhaul to a non-partisan group of lawmakers on the healthcare industry, reiterating its case for the price maintenance...read more